MicroRNAs: Biomarkers, Diagnostics, and Therapeutics

MicroRNAs: Biomarkers, Diagnostics, and Therapeutics
复制标题

DOI:
10.1007/978-1-4939-7046-9_4
复制
发表时间:
2017-01-01
期刊:
BIOINFORMATICS IN MICRORNA RESEARCH
影响因子:
--
通讯作者:
Huang, Weili
Huang, Weili
中科院分区:
其他
文献类型:
--
作者:
Huang, Weili

文献摘要

被引文献

相似文献

MicroRNA(miRNAs)是一类长度为21-23个核苷酸的非编码小RNA,在翻译或翻译后水平调控基因表达。主要的调节机制包括翻译抑制或mRNA降解(Filipowicz等人,Curr Opin Struct Biol 15:331-341,2005)。已经发现miRNA的异常表达与多种人类疾病相关,例如癌症/肿瘤、糖尿病、病毒感染、心血管疾病、神经变性疾病和其他疾病(Wang et al.,J Cell Physiol 23:25-30,2016; Lawrie,MicroRNAs in medicine,2013)。miRNA的表达是组织特异性的,并且可用于鉴定肿瘤类型及其起源(Mishra和梅尔利诺,J Clin Invest 119:2119-2123,2009)。许多研究表明,miRNA表达谱是多种人类疾病的新的诊断和预后生物标志物。操纵相关的miRNA表达或功能可能成为不同疾病的潜在治疗策略。
MicroRNAs (miRNAs) are small noncoding RNAs (21-23 nucleotides in length) that regulate gene expression at translational or posttranslational levels. The major regulatory mechanisms include translational repression or mRNA degradation (Filipowicz et al., Curr Opin Struct Biol 15: 331-341, 2005).Aberrant expression of miRNAs has been found to be associated with a variety of human diseases such as cancers/tumors, diabetes, viral infections, cardiovascular diseases, neurodegenerative diseases, and other diseases (Wang et al., J Cell Physiol 23: 25-30, 2016; Lawrie, MicroRNAs in medicine, 2013). The expression of miRNAs is tissue specific and can be used to identify tumor type and its origin (Mishra and Merlino, J Clin Invest 119: 2119-2123, 2009). Many investigations suggest that the miRNA-expression profiles are novel diagnostic and prognostic biomarkers for multiple human diseases. Manipulating relevant miRNA expression or function may serve as potential therapeutic strategies for different diseases.